Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Avelumab Antibody (1S157)

😃Good
Catalog No. TMAS-00012
Alias Bavencio

Anti-Avelumab Antibody (1S157) is a Mouse antibody targeting Avelumab. Anti-Avelumab Antibody (1S157) can be used in ELISA, Competitive ELISA.

Anti-Avelumab Antibody (1S157)

Anti-Avelumab Antibody (1S157)

😃Good
Catalog No. TMAS-00012Alias Bavencio
Anti-Avelumab Antibody (1S157) is a Mouse antibody targeting Avelumab. Anti-Avelumab Antibody (1S157) can be used in ELISA, Competitive ELISA.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
40 μg$3057-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Avelumab Antibody (1S157) is a Mouse antibody targeting Avelumab. Anti-Avelumab Antibody (1S157) can be used in ELISA, Competitive ELISA.
SynonymsBavencio
Ig Type
IgG1,κ
Clone
1S157
Specificity
Avelumab
Application
Recommended Dose
ELISA: 0.001-0.1 µg/ml; Competitive ELISA: 10-50 µg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
PurificationProtein A affinity column
AppearanceLyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
FormulationLyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Research BackgroundAvelumab with trade name Bavencio, is an FDA-approved drug to treat Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). PD-L1 can be highly expressed on certain tumors, which is thought to lead to reduced activation of immune cells (cytotoxic T-cells in particular) that might otherwise recognize and attack the cancer. Inhibition of PD-L1 by Avelumab can remove this inhibitor effect and thereby engender an anti-tumor response. It is one of several ways to block inhibitory signals related to T-cell activation, a more general strategy known as "immune checkpoint inhibition."
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Avelumab
Chemical Properties
Stability & Storage
Stability & StorageThe lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Avelumab Antibody (1S157) | purchase Anti-Avelumab Antibody (1S157) | Anti-Avelumab Antibody (1S157) cost | order Anti-Avelumab Antibody (1S157)